- Home
- RYET vs FENC Comparison
RYET vs FENC Comparison
Compare RYET & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYET
- FENC
- Stock Information
- Founded
- RYET 2012
- FENC 1996
- Country
- RYET China
- FENC United States
- Employees
- RYET N/A
- FENC N/A
- Industry
- RYET
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RYET
- FENC Health Care
- Exchange
- RYET NYSE
- FENC Nasdaq
- Market Cap
- RYET 176.2M
- FENC 156.9M
- IPO Year
- RYET 2025
- FENC 2001
- Fundamental
- Price
- RYET $7.51
- FENC $5.44
- Analyst Decision
- RYET
- FENC Strong Buy
- Analyst Count
- RYET 0
- FENC 2
- Target Price
- RYET N/A
- FENC $14.00
- AVG Volume (30 Days)
- RYET 808.2K
- FENC 78.4K
- Earning Date
- RYET 01-01-0001
- FENC 05-13-2025
- Dividend Yield
- RYET N/A
- FENC N/A
- EPS Growth
- RYET N/A
- FENC N/A
- EPS
- RYET N/A
- FENC N/A
- Revenue
- RYET $6,989,985.00
- FENC $47,538,000.00
- Revenue This Year
- RYET N/A
- FENC $2.68
- Revenue Next Year
- RYET N/A
- FENC $71.63
- P/E Ratio
- RYET N/A
- FENC N/A
- Revenue Growth
- RYET N/A
- FENC 123.69
- 52 Week Low
- RYET $4.00
- FENC $3.96
- 52 Week High
- RYET $8.34
- FENC $10.07
- Technical
- Relative Strength Index (RSI)
- RYET N/A
- FENC 44.82
- Support Level
- RYET N/A
- FENC $5.02
- Resistance Level
- RYET N/A
- FENC $5.50
- Average True Range (ATR)
- RYET 0.00
- FENC 0.38
- MACD
- RYET 0.00
- FENC 0.02
- Stochastic Oscillator
- RYET 0.00
- FENC 59.38
About RYET RUANYUN EDAI TECHNOLOGY INC
Ruanyun Edai Technology Inc is primarily engaged in providing online academic exercise question banks with A.I. capabilities, online classes and homework, and on-demand lectures and evaluations that cover all K-12 subject fields and grade levels.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.